|
As Executive Vice President of Strategic Development, Sanjay Sabnani oversees Hythiam’s intellectual property, scientific and corporate communications, and technology acquisition. Sabnani has a strong background in introducing innovative technologies to specialist markets. Sabnani is the co-author of Benzodiazepines and Other Sedative-Hypnotics in the forthcoming 4th edition of the American Psychiatric Association’s Textbook of Substance Abuse Treatment. He has also authored articles for publications such as the Los Angeles Business Journal. Sabnani graduated from the University of California in Los Angeles. | 